Acute Zonal Occult Outer Retinopathy (AZOOR)

Acute Zonal Occult Outer Retinopathy (AZOOR) is a rare retinal disease first described by J. Donald Gass in 1992. It is classified within the “white dot syndromes” and is characterized by the acute onset of one or more large zones of outer retinal dysfunction, typically presenting with photopsias (“flashing lights”) and scotomas (“blind spots”) despite a largely normal-appearing fundus upon examination Wikipediajournals.lww.com.

Acute Zonal Occult Outer Retinopathy (AZOOR) is a rare, idiopathic inflammatory retinopathy characterized by sudden dysfunction of the outer retina, particularly the photoreceptor layer, leading to acute visual field defects and photopsias with initially minimal funduscopic changes. First described by Donald Gass in 1992, it predominantly affects young to middle-aged adults, with a strong female preponderance, and often presents with abrupt onset of “whitening” or blurring of vision and persistent scintillations in one or more large zones of the visual field Wikipedia. Electroretinography typically shows reduced outer retinal responses, and multimodal imaging (optical coherence tomography, fundus autofluorescence) reveals zonal disruptions in the ellipsoid zone and irregular autofluorescence patterns EyeWiki.

AZOOR is grouped within the “white dot syndromes,” though its fundus appearance may remain unremarkable early on. Over weeks to months, patients can develop peripapillary grayish-white lines and pigmentary changes at the border of affected zones. Visual acuity may be preserved despite marked scotomas, and the disease can progress to involve the fellow eye in a significant proportion of cases ajo.com. The exact etiology remains unknown, with hypotheses including a viral trigger or immune-mediated attack on photoreceptors.

Patients with AZOOR exhibit functional loss of photoreceptors with minimal or delayed pigmentary changes in the retinal pigment epithelium (RPE). Electroretinography (ERG) shows global cone-system delays, and fundus autofluorescence (FAF) and optical coherence tomography (OCT) reveal a characteristic “trizonal” pattern of involvement: (1) normal autofluorescence outside the lesion; (2) speckled hyperautofluorescence within the lesion; and (3) hypoautofluorescence indicating RPE atrophy in advanced zones EyeWikiEyeWiki.

AZOOR predominantly affects young to middle-aged adults—especially Caucasian females in their 30s—though it can occur at any age and in all ethnicities. Its exact etiology remains unknown, but prevailing theories implicate autoimmune and viral triggers leading to outer retinal inflammation and photoreceptor damage EyeWikijournals.lww.com.

---

Types of AZOOR

Type 1 (Primary AZOOR):
This form presents as an isolated zonal loss of outer retinal function without preceding white dot syndromes. Funduscopic examination is initially unremarkable or shows subtle RPE mottling. Multimodal imaging reveals peripapillary hypoautofluorescence and a demarcating line between healthy and affected retina, following a trizonal pattern on OCT and FAF EyeWikiPubMed.

Type 2 (Secondary AZOOR):
Here, AZOOR lesions develop in eyes with other white dot syndromes (e.g., MEWDS, multifocal choroiditis). The initial presentation may mimic those syndromes, but subsequent widespread photoreceptor loss and zonal progression distinguish it. Imaging shows combined features of both conditions, with diffuse outer retinal atrophy overlaying focal white-dot lesions ScienceDirectPubMed.

Type 3 (Chronic/Complex AZOOR):
Advanced cases exhibit irreversible photoreceptor and RPE loss, choroidal atrophy, and attenuated retinal vessels. Clinically, pigmentary disturbances simulate retinitis pigmentosa. OCT demonstrates thinning of the outer and inner nuclear layers, while FAF shows extensive hypoautofluorescence. These cases often follow a prolonged course with bilateral involvement and poor visual prognosis EyeWikiPMC.

---

Proposed Causes

Note: While the precise cause of AZOOR remains idiopathic, studies suggest several contributory factors.

1. Autoimmune Inflammation
   An autoimmune process targeting photoreceptors and RPE is supported by female predominance and associations with systemic autoimmune diseases (e.g., thyroiditis, multiple sclerosis) EyeWikiEyeWiki.

2. Viral Prodrome
   Up to 20% of patients report flu-like symptoms preceding onset, suggesting a viral trigger (e.g., herpesviruses) that may initiate retinal inflammation EyeWikiEyeWiki.

3. Photoreceptor Outer Segment Damage
   Primary injury at the photoreceptor outer segments, as shown by OCT, implies direct photoreceptor toxicity or immune-mediated destruction MDPIjournals.lww.com.

4. Antiretinal Antibodies
   In one series, all AZOOR patients had detectable antiretinal antibodies on Western blot, although their pathogenic role remains unclear EyeWikiEyeWiki.

5. White Dot Syndrome Overlap
   AZOOR may represent the end-stage of other white dot syndromes; shared inflammatory pathways could underlie both phenotypes EyeWikiWikipedia.

6. Genetic Predisposition
   No specific genes have been identified, but familial clustering in rare cases suggests a possible genetic susceptibility journals.lww.com.

7. Myopia
   Nearsighted individuals appear overrepresented, potentially due to structural retinal vulnerabilities EyeWikiConnectCenter.

8. Hormonal Influences
   The strong female predominance hints at estrogen-mediated modulation of immune responses in the retina Wikipedia.

9. Choroidal Vascular Compromise
   Some imaging studies show choriocapillaris hypoperfusion, suggesting ischemic contributions to outer retinal damage EyeWikiEyeWiki.

10. Immune Complex Deposition
    Deposits in the outer retina may trigger local inflammation and photoreceptor loss, analogous to paraneoplastic retinopathies EyeWikijournals.lww.com.

11. Environmental Toxins
    Rare exposures (e.g., Candida famata infection) have been reported, though direct causation is unproven Wikipedia.

12. Oxidative Stress
    Accumulation of reactive oxygen species in photoreceptors could precipitate zonal damage under inflammatory conditions journals.lww.com.

13. Cytokine Dysregulation
    Elevated pro-inflammatory cytokines in ocular fluids may mediate photoreceptor apoptosis EyeWikijournals.lww.com.

14. Breakdown of Blood–Retinal Barrier
    Subtle barrier breaches could allow serum components to contact photoreceptors, igniting inflammation EyeWikijournals.lww.com.

15. Idiopathic Mechanisms
    In many cases, no identifiable trigger is found, underscoring the idiopathic nature of AZOOR Wikipedia.

---

Symptoms

1. Photopsia (Flashing Lights)
   Patients describe scintillating or shimmering lights, often preceding or accompanying visual field loss EyeWikijournals.lww.com.

2. Scotoma (Blind Spots)
   A sudden awareness of areas of missing vision, corresponding to zones of photoreceptor dysfunction EyeWikiMDPI.

3. Visual Field Defects
   Confrontation and automated perimetry reveal enlarged blind spots, central/paracentral scotomas, or constricted fields EyeWikiEyeWiki.

4. Mild Reduction in Visual Acuity
   Central acuity is often preserved early but can decline if the macula is involved EyeWikijournals.lww.com.

5. Delayed Fundus Changes
   Initially, the fundus appears normal; RPE mottling or pigmentary disturbances develop weeks to months later EyeWikijournals.lww.com.

6. Minimal Anterior Segment Inflammation
   The anterior chamber is usually quiet, though mild vitreous cells may appear in late stages EyeWikiEyeWiki.

7. Bilateral Progression
   Although often unilateral at onset, up to 76% progress to involve the second eye over years EyeWikiEyeWiki.

8. Photophobia
   Light sensitivity may accompany photopsias and exacerbate discomfort MalaCards.

9. Night Vision Difficulties
   Rod dysfunction within affected zones can impair scotopic (low-light) vision MalaCards.

10. Variable Course and Recovery
    Some patients experience stabilization within six months, while others progress to permanent field loss EyeWikiEyeWiki.

---

Diagnostic Tests

Physical Examination

1. Visual Acuity Testing
   Measures central vision; often near normal early in AZOOR but can decline if the macula is affected EyeWikijournals.lww.com.

2. Pupillary Light Reflex
   Typically normal, helping exclude optic neuropathies Wikipedia.

Manual Functional Tests

3. Confrontation Visual Fields
   A quick bedside check to identify large scotomas EyeWikiEyeWiki.

4. Amsler Grid
   Detects central metamorphopsia or paracentral scotomas when patients fixate on a central dot ConnectCenter.

Laboratory and Pathological Tests

5. Western Blot for Antiretinal Antibodies
   Assesses autoimmune markers; positive in many AZOOR cases but not specific EyeWikiEyeWiki.

6. Viral Serologies
   Identifies recent infections (e.g., HSV, VZV) in patients with prodromal illness EyeWikiEyeWiki.

7. Autoimmune Panel (ANA, RF, ENA)
   Screens for systemic autoimmune diseases sometimes associated with AZOOR EyeWikiEyeWiki.

8. Inflammatory Markers (ESR, CRP)
   May be mildly elevated during active inflammation EyeWikiEyeWiki.

Electrodiagnostic Tests

9. Full-Field Electroretinography (ffERG)
   Shows global cone-system delays (e.g., 30-Hz flicker implicit time) despite localized lesions EyeWikiMDPI.

10. Multifocal ERG (mfERG)
    Maps localized outer retinal dysfunction corresponding to scotomas EyeWikiMDPI.

11. Electro-oculogram (EOG)
    May show reduced light rise but is less sensitive in AZOOR EyeWikiEyeWiki.

12. Visual Evoked Potentials (VEP)
    Excludes optic nerve involvement by confirming normal cortical responses Wikipedia.

Imaging Tests

13. Fundus Photography
    Documents subtle RPE changes and pigmentary disturbances over time EyeWikiEyeWiki.

14. Spectral-Domain OCT (SD-OCT)
    Reveals loss of ellipsoid/interdigitation zones and trizonal outer retinal changes EyeWikiEyeWiki.

15. Fundus Autofluorescence (FAF)
    Defines lesion extent and documents hyper-/hypoautofluorescence patterns EyeWikiEyeWiki.

16. Fluorescein Angiography (FA)
    Early normal appearance with late window defects and RPE staining EyeWikiEyeWiki.

17. Indocyanine Green Angiography (ICG)
    May reveal late hypofluorescence or a trizonal pattern in chronic lesions EyeWikiEyeWiki.

18. Optical Coherence Tomography Angiography (OCTA)
    Detects secondary choroidal neovascularization in rare complicated cases journals.lww.com.

19. Adaptive Optics Imaging
    Visualizes cone photoreceptor loss at the lesion border EyeWikiEyeWiki.

20. B-Scan Ultrasonography / Orbital MRI
    Excludes posterior scleritis and optic nerve lesions when differential diagnosis remains broad EyeWikiWikipedia.

Non-Pharmacological Treatments

Physiotherapy and Electrotherapy Therapies

1. Eccentric Viewing Training
   This specialized rehabilitation teaches patients to use healthy peripheral retinal areas for fixation, bypassing central scotomas to improve reading speed and activities of daily living. Through guided practice with vision therapists, users learn to orient text or objects into functioning zones, enhancing practical vision despite central defects PMC.

2. Microperimetry Biofeedback
   Microperimetry assesses scotoma location and retinal sensitivity, then provides auditory or visual feedback as patients attempt to fixate targets in healthier retinal areas. This neuro-visual training promotes cortical adaptation, gradually improving fixation stability and functional peripheral vision Wikipedia.

3. Computerized Visual Scanning Training
   Using software that displays stimuli across the visual field, this therapy encourages systematic scanning patterns to expand patients’ usable visual field. Over repeated sessions, patients demonstrate reduced reading errors and faster target localization, reflecting enhanced use of peripheral vision Taylor & Francis Online.

4. Amsler Grid Rehabilitation
   Daily at-home practice with the Amsler grid helps patients detect metamorphopsia and enlarging scotomas early. Regular self-monitoring educates patients about subtle visual changes and promotes timely medical review Wikipedia.

5. Photobiomodulation (Low-Level Light Therapy)
   Application of near-infrared or red light wavelengths to the retina stimulates mitochondrial cytochrome C oxidase, enhancing cellular energy production and promoting photoreceptor survival. Early human studies suggest potential stabilization of visual field defects in outer retinal degenerations Frontiers.

6. Transcranial Direct Current Stimulation (tDCS)
   Non-invasive electrodes placed on the scalp deliver weak electrical currents to the visual cortex, modulating cortical excitability and enhancing residual visual function. Preliminary trials show improved contrast sensitivity and transient visual field expansion in retinal disease Wikipedia.

7. Transcorneal Electrical Stimulation (TES)
   Weak electrical pulses delivered via corneal contact lens electrodes stimulate retinal cells directly, promoting photoreceptor survival and delaying degeneration. Animal and early human studies report preserved retinal thickness and improved electrophysiologic responses PubMed.

8. Transpalpebral Electrical Stimulation
   Electrical stimulation through the eyelid has been shown to preserve photoreceptor function and induce retinal neurotrophic factor release, offering a non-invasive alternative to TES with promising preclinical results IOVS.

9. Prism Glasses Adaptation
   Prism lenses shift images from scotomatous zones onto healthier retinal areas, reducing blind-spot impact during reading and mobility tasks. Customized prism placement can significantly improve visual comfort and performance Wikipedia.

10. Magnification and Contrast Enhancement Devices
    Hand-held or stand magnifiers with adjustable contrast settings assist patients with central scotomas in reading printed text and recognizing faces, leveraging residual peripheral vision for enhanced visual clarity Wikipedia.

Exercise Therapies

1. Saccadic Eye Movement Training
   Structured exercises prompt rapid, repeated eye jumps (saccades) across target patterns to improve scanning efficiency and reduce time to locate objects in the visual field Taylor & Francis Online.

2. Smooth Pursuit Practice
   Patients track moving targets smoothly across the field, enhancing oculomotor control and reducing reliance on head movements for visual scanning Wikipedia.

3. Dynamic Visual Acuity Workouts
   Exercises where patients identify moving letters or symbols help maintain recognition speed and support residual central field function Wikipedia.

4. Eye-Hand Coordination Drills
   Activities such as ball tosses and touchscreen tracing tasks improve visuomotor integration, critical for tasks like reaching and navigation in compromised visual fields Wikipedia.

5. Contrast Sensitivity Exercises
   Patients practice distinguishing grayscale gradations on digital apps, aiming to slow contrast sensitivity decline associated with outer retinal damage Wikipedia.

Mind-Body Therapies

1. Guided Meditation and Relaxation
   Mindfulness practices reduce stress-induced exacerbation of visual symptoms and may modulate inflammatory responses through autonomic nervous system regulation Wikipedia.

2. Visual Imagery Training
   Patients mentally rehearse scanning environments and visual tasks, enhancing cortical visual mapping and compensatory strategies even without direct eye movement Wikipedia.

3. Cognitive Behavioral Therapy (CBT)
   CBT addresses anxiety and depression arising from sudden vision loss, teaching coping strategies that support adherence to rehabilitation exercises and improve overall quality of life Wikipedia.

Educational Self-Management

1. Patient Education Workshops
   Group sessions led by low vision specialists inform patients about AZOOR mechanisms, available therapies, and adaptive techniques, empowering self-management Wikipedia.

2. Vision Self-Monitoring Diaries
   Structured logs for patients to record daily visual function, photopsia frequency, and symptom triggers enhance self-awareness and facilitate clinician-patient communication during follow-up Wikipedia.

---

Evidence-Based Drugs

1. Oral Prednisone (Systemic Corticosteroid)
   Dosage: 1 mg/kg daily (up to 60 mg/day) for 4–6 weeks, then gradual taper; Class: Glucocorticoid; Time: Morning to mimic circadian cortisol rhythm; Side Effects: Weight gain, hypertension, hyperglycemia, mood changes PubMed.

2. Intravenous Methylprednisolone
   Dosage: 1 g IV daily for 3 days; Class: Glucocorticoid; Time: Once daily infusion; Side Effects: Insomnia, electrolyte imbalance, immunosuppression PubMed.

3. Mycophenolate Mofetil
   Dosage: 1 g twice daily; Class: Antimetabolite immunosuppressant; Time: Morning and evening; Side Effects: Gastrointestinal upset, leukopenia, increased infection risk PubMed.

4. Azathioprine
   Dosage: 1–2 mg/kg daily; Class: Purine analog immunosuppressant; Time: Single daily dose; Side Effects: Hepatotoxicity, bone marrow suppression, gastrointestinal discomfort PubMed.

5. Methotrexate
   Dosage: 7.5–15 mg weekly; Class: Folate antagonist; Time: Weekly administration; Side Effects: Mucositis, hepatotoxicity, pulmonary fibrosis PubMed.

6. Cyclosporine
   Dosage: 2–5 mg/kg daily in divided doses; Class: Calcineurin inhibitor; Time: Twice daily; Side Effects: Nephrotoxicity, hypertension, tremor PubMed.

7. Infliximab
   Dosage: 5 mg/kg IV at weeks 0, 2, 6 then every 8 weeks; Class: Anti-TNF-α monoclonal antibody; Side Effects: Infusion reactions, infection risk PubMed.

8. Rituximab
   Dosage: 375 mg/m² IV weekly × 4 weeks; Class: Anti-CD20 monoclonal antibody; Side Effects: Infusion reactions, neutropenia PubMed.

9. Methotrexate Pulse Therapy
   Dosage: 1 g/m² IV monthly; Class: Antimetabolite; Side Effects: Hepatotoxicity, mucositis PubMed.

10. Intravenous Immunoglobulin (IVIG)
    Dosage: 2 g/kg divided over 2–5 days; Class: Immunomodulator; Side Effects: Headache, thromboembolic events PubMed.

---

Dietary Molecular Supplements

1. Lutein
   Dosage: 10 mg daily; Functional: Macular pigment enhancer; Mechanism: Filters blue light and acts as antioxidant Wikipedia.

2. Zeaxanthin
   Dosage: 2 mg daily; Functional: Macular pigment support; Mechanism: Quenches free radicals in photoreceptors Wikipedia.

3. Omega-3 Fatty Acids (DHA/EPA)
   Dosage: 1 g combined DHA/EPA daily; Functional: Anti-inflammatory; Mechanism: Modulates retinal inflammation, supports photoreceptor membrane integrity Wikipedia.

4. Vitamin C
   Dosage: 500 mg twice daily; Functional: Water-soluble antioxidant; Mechanism: Neutralizes reactive oxygen species in ocular tissues Wikipedia.

5. Vitamin E
   Dosage: 400 IU daily; Functional: Lipid-soluble antioxidant; Mechanism: Protects photoreceptor membranes from oxidative damage Wikipedia.

6. Beta-Carotene (Vitamin A precursor)
   Dosage: 15 mg daily; Functional: Photopigment precursor; Mechanism: Supports visual cycle and photoreceptor health Wikipedia.

7. Zinc
   Dosage: 80 mg daily; Functional: Trace mineral cofactor; Mechanism: Supports antioxidant enzyme activity and retinal metabolism Wikipedia.

8. Copper
   Dosage: 2 mg daily; Functional: Cofactor to prevent zinc-induced copper deficiency; Mechanism: Supports superoxide dismutase activity Wikipedia.

9. Ginkgo Biloba Extract
   Dosage: 120 mg standardized extract daily; Functional: Neuroprotective and vascular modulator; Mechanism: Enhances ocular blood flow and reduces oxidative stress PMC.

10. Curcumin
    Dosage: 500 mg twice daily; Functional: Anti-inflammatory, antioxidant; Mechanism: Inhibits NF-κB pathway, protects photoreceptors PMC.

---

Advanced Regenerative and Cell-Based Drugs

1. Alendronate (Bisphosphonate)
   Dosage: 70 mg orally once weekly; Functional: Antiresorptive; Mechanism: Hypothesized to modulate microglial activation, though evidence for AZOOR is lacking and ocular inflammation is a known adverse effect PubMed.

2. Recombinant Human Nerve Growth Factor (Cenegermin)
   Dosage: Ophthalmic 0.002% solution, one drop six times daily for 8 weeks; Functional: Neurotrophic; Mechanism: TrkA agonist promoting photoreceptor survival Wikipedia.

3. Sodium Hyaluronate (Viscosupplementation)
   Dosage: Intravitreal 0.1 mL of 1 mg/mL; Functional: Vitreous substitute drug delivery; Mechanism: Provides mechanical support and sustained release scaffold for adjunct therapies Wikipedia.

4. Mesenchymal Stem Cell-Derived Exosomes
   Dosage: Experimental intravitreal injection of 50 µL cell-free exosome preparation; Functional: Regenerative; Mechanism: Delivers trophic factors to rescue photoreceptors; clinical trials ongoing Wikipedia.

5. Voretigene Neparvovec (Gene Therapy)
   Dosage: 1.5 ×10^11 vector genomes subretinal once; Functional: Gene augmentation; Mechanism: Delivers functional RPE65 gene to RPE cells, illustrating potential for genetic outer retinal repair PMC.

6. Erythropoietin
   Dosage: 33,000 IU IV weekly for 4 weeks; Functional: Neuroprotective cytokine; Mechanism: Activates erythropoietin receptor signaling to inhibit apoptosis in photoreceptors Wikipedia.

---

Surgical Interventions

1. Pars Plana Vitrectomy
   Procedure: Three-port removal of vitreous gel to clear inflammatory mediators and perform adjunct treatments; Benefits: Enables direct access for subretinal gene therapy or stem cell delivery Wikipedia.

2. Scleral Buckling
   Procedure: Silicone band encircling the globe to support peripheral retina; Benefits: Stabilizes retinal architecture, useful if AZOOR leads to secondary tractional detachments Wikipedia.

3. Retinal Prosthesis (Argus II)
   Procedure: Epiretinal implant converting visual scenes into electrical pulses; Benefits: Provides rudimentary vision in severe outer retinal loss, illustrating potential artificial vision strategies Wikipedia.

4. Subretinal RPE/Photoreceptor Transplant
   Procedure: Injection or graft of RPE or photoreceptor progenitors derived from stem cells; Benefits: Aims to restore lost outer retinal cells, with early-phase trials reporting safety and integration Wikipedia.

5. Photodynamic Therapy (Verteporfin PDT)
   Procedure: Intravenous verteporfin followed by retinal laser activation to occlude abnormal vessels; Benefits: May address secondary choroidal neovascularization and limit further outer retinal damage PMC.

Prevention Strategies

1. Wear 100% UV-Blocking Sunglasses
   Protects retina from cumulative UV damage associated with macular and outer retinal degeneration National Eye Institute.

2. Use Broad-Brimmed Hats Outdoors
   Further reduces ocular UV exposure, especially during peak sun hours National Eye Institute.

3. Follow a Diet Rich in Antioxidants
   Include colorful fruits, vegetables, and leafy greens to supply lutein, zeaxanthin, and vitamins C/E Wikipedia.

4. Avoid Smoking
   Smoking is a known risk factor for retinal oxidative stress and inflammatory ocular diseases Verywell Health.

5. Manage Systemic Health
   Control hypertension, diabetes, and hyperlipidemia to reduce microvascular stress on the retina Verywell Health.

6. Regular Eye Examinations
   Early detection of scotomas or fundus changes allows prompt intervention Verywell Health.

7. Limit Prolonged Screen Time
   Employ the 20-20-20 rule (every 20 minutes, look 20 feet away for 20 seconds) to reduce digital eye strain and maintain tear film PMC.

8. Ensure Proper Lighting and Contrast
   Use adjustable ambient lighting and screen settings to minimize glare and optimize visual comfort PMC.

9. Stay Hydrated
   Adequate hydration supports ocular surface health and nutrient delivery to the retina Verywell Health.

10. Use Low-Vision Aids Early
    Introduce magnifiers and contrast enhancements at first signs of scotoma to maintain independence Wikipedia.

---

When to See a Doctor

• Sudden Onset of Photopsias or Scotomas
  Acute flashes of light or new blind spots warrant immediate ophthalmic evaluation Wikipedia.

• Persistent Blurred Vision or Visual Distortion
  Unresolved changes over 24–48 hours may indicate progressive outer retinal damage Specialty Vision.

• Changes on Amsler Grid Self-Testing
  New lines or box distortions should trigger prompt follow-up Wikipedia.

• Worsening of Visual Field Defects
  Rapid expansion of scotomas necessitates repeat imaging and electrophysiology EyeWiki.

• Development of Pain or Redness
  Suggests possible inflammatory complications or alternative diagnoses requiring urgent care Wikipedia.

---

What to Do and What to Avoid

What to Do

1. Maintain scheduled immunosuppressive therapy and follow ophthalmologist’s instructions.

2. Perform daily low-vision and self-monitoring exercises.

3. Adhere to dietary supplement regimens as prescribed.

4. Use protective eyewear for UV and blue-light filtering when outdoors or at screens.

5. Keep hydration and systemic health optimized.

What to Avoid

1. Smoking and second-hand smoke exposure.

2. Unsupervised use of ocular or systemic medications.

3. High-impact sports or activities risking ocular trauma.

4. Prolonged exposure to bright, direct sunlight without UV protection.

5. Excessive screen time without regular breaks.

---

 Frequently Asked Questions

1. What is AZOOR?
   AZOOR is a rare inflammatory retinopathy causing acute outer retinal dysfunction with photopsias and visual field defects Wikipedia.

2. Who is affected?
   It most commonly affects Caucasian females in their mid-thirties but can occur in any demographic Wikipedia.

3. What causes AZOOR?
   The etiology is unknown; hypotheses include viral triggers and autoimmune photoreceptor attack Wikipedia.

4. What are the symptoms?
   Sudden photopsias (flashes), central or paracentral scotomas, and mild visual acuity changes Wikipedia.

5. How is it diagnosed?
   Diagnosis relies on clinical exam, visual field testing, ERG abnormalities, OCT outer retinal disruption, and fundus autofluorescence EyeWiki.

6. What tests are used?
   Full-field and multifocal ERG, automated perimetry, OCT, fluorescein angiography, and autofluorescence imaging EyeWiki.

7. What treatments are available?
   High-dose corticosteroids and immunosuppressants are used empirically, though efficacy is variable PubMed.

8. What is the prognosis?
   Prognosis is variable; some patients stabilize, while others develop bilateral involvement or permanent scotomas ajo.com.

9. Can AZOOR recur?
   Yes; fellow-eye involvement and recurrences in the same eye are reported in long-term follow-up ajo.com.

10. Can vision recover?
    Partial recovery of scotomas may occur, but many patients retain some lasting field defects ajo.com.

11. Is it hereditary?
    No genetic inheritance pattern has been identified; AZOOR is considered nonhereditary Wikipedia.

12. How is AZOOR different from MEWDS?
    Both are white dot syndromes, but MEWDS often resolves spontaneously with distinct white dots, whereas AZOOR features persistent zonal photoreceptor loss Wikipedia.

13. Does AZOOR cause blindness?
    Complete blindness is rare, but large scotomas can significantly impair daily activities journals.lww.com.

14. How common is AZOOR?
    It is extremely rare, with no precise incidence data; Orphanet classifies it as a very rare disorder Orpha.

15. Where can I find support?
    Patient advocacy groups such as Rare Diseases Info (GARD) offer resources for education and community rarediseases.info.nih.gov.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 10, 2025.